“Cystatin C takes part in melanoma-microglia cross-talk: possible implications for brain metastasis.”
Moshe, A., S. Izraely, O. Sagi-Assif, R. Prakash, A. Telerman, T. Meshel, T. Carmichael and I. P. WitzClin Exp Metastasis, 2018.
Clin Exp Metastasis, 2018.
“Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma.”
Mullinax, J. E., M. Hall, S. Prabhakaran, J. Weber, N. Khushalani, Z. Eroglu, A. S. Brohl, J. Markowitz, E. Royster, A. Richards, V. Stark, J. S. Zager, L. Kelley, C. Cox, V. K. Sondak, J. J. Mule, S. Pilon-Thomas and A. A. SarnaikFront Oncol, 2018.
“MITF and UV responses in skin: from pigmentation to addiction.”
Nguyen, N. T. and D. E. FisherPigment Cell Melanoma Res, 2018.
“A slow-cycling subpopulation of melanoma cells with highly invasive properties.”
Perego, M., M. Maurer, J. X. Wang, S. Shaffer, A. C. Muller, K. Parapatics, L. Li, D. Hristova, S. Shin, F. Keeney, S. Liu, X. Xu, A. Raj, J. K. Jensen, K. L. Bennett, S. N. Wagner, R. Somasundaram and M. HerlynOncogene, 2018.
“Epigenetic profiling for the molecular classification of metastatic brain tumors.”
Orozco, J. I. J., T. A. Knijnenburg, A. O. Manughian-Peter, M. P. Salomon, G. Barkhoudarian, J. R. Jalas, J. S. Wilmott, P. Hothi, X. Wang, Y. Takasumi, M. E. Buckland, J. F. Thompson, G. V. Long, C. S. Cobbs, I. Shmulevich, D. F. Kelly, R. A. Scolyer, D. S. B. Hoon and D. M. MarzeseNat Commun, 2018.
“Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy.”
Kim, S. H., J. Roszik, E. A. Grimm and S. EkmekciogluFront Oncol, 2018.
“Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production.”
Konno, H., S. Yamauchi, A. Berglund, R. M. Putney, J. J. Mule and G. N. BarberOncogene, 2018.
“Multiplex Gene Profiling of Cell-Free DNA in Patients With Metastatic Melanoma for Monitoring Disease.”
Lin, S. Y., S. K. Huang, K. T. Huynh, M. P. Salomon, S.-C. Chang, D. M. Marzese, R. B. Lanman, A. Talasz and D. HoonJCO Precison Oncology, 2018.
“Loss of Phd2 cooperates with BRAF(V600E) to drive melanomagenesis.”
Liu, S., G. Zhang, J. Guo, X. Chen, J. Lei, K. Ze, L. Dong, X. Dai, Y. Gao, D. Song, B. Ecker, R. Yang, C. Feltcher, K. Peng, C. Feng, H. Chen, R. X. Lee, H. Kerestes, J. Niu, S. Kumar, W. Xu, J. Zhang, Z. Wei, J. S. Martin, X. Liu, G. Mills, Y. Lu, W. Guo, L. Sun, L. Zhang, A. Weeraratna, M. Herlyn, W. Wei, F. S. Lee and X. XuNat Commun, 2018.
“A history of exploring cancer in context.”
Maman, S. and I. P. WitzNat Rev Cancer, 2018.
“Alternative splicing and cancer metastasis: prognostic and therapeutic applications.”
Marzese, D. M., A. O. Manughian-Peter, J. I. J. Orozco and D. S. B. HoonClin Exp Metastasis, 2018.
“Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.”
McQuade, J. L., C. R. Daniel, K. R. Hess, C. Mak, D. Y. Wang, R. R. Rai, J. J. Park, L. E. Haydu, C. Spencer, M. Wongchenko, S. Lane, D. Y. Lee, M. Kaper, M. McKean, K. E. Beckermann, S. M. Rubinstein, I. Rooney, L. Musib, N. Budha, J. Hsu, T. S. Nowicki, A. Avila, T. Haas, M. Puligandla, S. Lee, S. Fang, J. A. Wargo, J. E. Gershenwald, J. E. Lee, P. Hwu, P. B. Chapman, J. A. Sosman, D. Schadendorf, J. J. Grob, K. T. Flaherty, D. Walker, Y. Yan, E. McKenna, J. J. Legos, M. S. Carlino, A. Ribas, J. M. Kirkwood, G. V. Long, D. B. Johnson, A. M. Menzies and M. A. DaviesLancet Oncol, 2018.
“Local genomic features predict the distinct and overlapping binding patterns of the bHLH-Zip family oncoproteins MITF and MYC-MAX.”
Hejna, M., W. M. Moon, J. Cheng, A. Kawakami, D. E. Fisher and J. S. SongPigment Cell Melanoma Res, 2018.
“MSX1-Induced Neural Crest-Like Reprogramming Promotes Melanoma Progression.”
Heppt, M. V., J. X. Wang, D. M. Hristova, Z. Wei, L. Li, B. Evans, M. Beqiri, S. Zaman, J. Zhang, M. Irmler, C. Berking, R. Besch, J. Beckers, F. J. R. Rauscher, R. A. Sturm, D. E. Fisher, M. Herlyn and M. Fukunaga-KalabisJ Invest Dermatol, 2018.
“Predominance of triple wild-type and IGF2R mutations in mucosal melanomas.”
Iida, Y., M. P. Salomon, K. Hata, K. Tran, S. Ohe, C. F. Griffiths, S. C. Hsu, N. Nelson and D. S. B. HoonBMC Cancer, 2018.
“The Metastatic Microenvironment: Melanoma-Microglia Cross-Talk Promotes the Malignant Phenotype of Melanoma Cells.”
Izraely, S., S. Ben-Menachem, O. Sagi-Assif, A. Telerman, I. Zubrilov, O. Ashkenazi, T. Meshel, S. Maman, J. I. J. Orozco, M. P. Salomon, D. M. Marzese, M. Pasmanik-Chor, E. Pikarsky, M. Ehrlich, D. S. B. Hoon and I. P. WitzInt J Cancer, 2018.